Pm. Schiltz et al., INCREASED ICAM-1 EXPRESSION IN THE EARLY STAGES OF MURINE CHRONIC GRAFT-VERSUS-HOST DISEASE, Clinical immunology and immunopathology, 71(2), 1994, pp. 136-141
Chronic graft-versus-host disease (cGVHD) is considered to be a model
for scleroderma, and vascular changes are considered to be important i
n that disease. We have examined the expression of intercellular adhes
ion molecule-1 (ICAM-1) and lymphocyte function associated antigen-1 (
LFA-1) using monoclonal antibodies and immunohistochemistry in very ea
rly murine cGVHD. ICAM-1 is found on a number of cell types including
endothelial cells. It is the natural ligand for LFA-1 found on leukocy
tes. Adherence of leukocytes to ICAM-1 positive cells is mediated by L
FA-1 and this binding is thought to play an important role in a number
of cell adhesion events in immune reactions. Experimental cGVHD acros
s minor histocompatibility barriers is established by the iv inoculum
of B10.D2 spleen cells into a a sublethally irradiated BALB/c host. Ea
r and skin biopsies were taken at Days 0-5 and from Days 14 to 120 pos
tinoculum. In comparison to the control group (BALB/c spleen cells giv
en to a sublethally irradiated BALB/c host), the cGVHD mice show incre
ased ICAM-1 expression by Day 3 on endothelial cells and mononuclear c
ells (MNC) and on fibroblast-like cells by Day 4. By Day 14, there are
increasing numbers of ICAM-1-expressing cells and increased epidermal
reactivity for ICAM-1; and finally, an increased number of LFA-1 posi
tive infiltrating MNC. These changes wane by Day 28 and are gone by Da
y 120. These results support the concept that ICAM-1/LFA-1 interaction
s play a role in the immune regulation of cGVHD. The very early upregu
lation of ICAM-1 on the endothelium indicates that this cell type may
be playing a primary role in cGVHD, and this model should provide a si
mple system in which to test regulation of endothelial activation in v
ivo. (C) 1994 Academic Press, Inc.